- Lobbying
- John AND Larkin
Lobbying Arrangements Results for 'John Larkin'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details S. 1194 - Recycling and Composting Accountability Act, All Titles S. 1189 - Recycling Infrastructure and Accessibility Act, All Titles Critical Minerals HR 4040 - The Recycling and Composting Accou... |
THE ALUMINUM ASSOCIATION, INC.
|
in-house lobbying | |||
Details Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C pol... |
Gilead Sciences, Inc.
|
BGR Government Affairs | |||
Details BGR provides strategic guidance on government policies relating to procurement of face masks. |
Medicom Group
|
BGR Government Affairs | |||
Details Funding for Corporation for Public Broadcasting, public television interconnection, Dept. of Education's Ready To Learn program, and FEMA IPAWS Next Generation Warning System grants for public safe... |
PUBLIC BROADCASTING SERVICE
|
in-house lobbying | |||
Details Mental Health Proposals Surprise Medical Billing Short Term Insurance Digital Healthcare Communications Value Based Care Medicare Advantage Medicaid and Commercial Market Coverage Policy Medicare ... |
UNITEDHEALTH GROUP, INC.
|
in-house lobbying | |||
Details Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically |
Alkermes, Inc.
Biopharmaceutical company |
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Zogenix specifically. |
Zogenix, Inc.
|
BGR Government Affairs | |||
Details Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues |
Eli Lilly & Co, Inc.
|
BGR Government Affairs | |||
Details Credit Card Competition Act Payments Card Standards, Security and Fraud Merchant Credit Card Acceptance Fees Supermarket Tax Credit for Underserved Areas Act Permanent extension of 100% bonus depre... |
National Grocers Association
|
in-house lobbying | |||
Details FY24 appropriations Potential Emergency Supplemental for Humanitarian Assistance 2023 Farm Bill Safe from the Start Act (upcoming) PEPFAR Reauthorization (upcoming) Support UNFPA Funding Act (upc... |
CARE Action Now, Inc.
|
in-house lobbying | |||
Details Advise and advocate on clients behalf regarding ongoing public policy concerns impacting the innovative biopharmaceutical industry in Congress and throughout the Administration. |
Pharmaceutical Research and Manufacturers of America
|
BGR Government Affairs | |||
Details Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid and FDA |
GlaxoSmithKline, INC
|
BGR Government Affairs | |||
Details Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Ca... |
Amgen Inc.
|
BGR Government Affairs | |||
Details Provide guidance and counsel with regard to federal medical device policy and regulatory issues and reimbursement issues within Medicare program, including IPPS Regulation, and FDA regulatory policy. |
Abiomed Inc.
|
BGR Government Affairs |